SCHEMBL17653196

SCHEMBL17653196

CC(C)CCN(C(=O)OCc1ccccc1)c1nc2ccc(C=O)cc2c(=O)[nH]1

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
AAK1 Q2M2I8 3/20 0.39
ALDH1A1 P00352 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.37
IP6K1 Q92551 1/20 0.36
MEN1 O00255 1/20 0.36
HTT P42858 1/20 0.36
KMT2A Q03164 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
TDP1 Q9NUW8 1/20 0.35
KDM4E B2RXH2 2/20 0.35
LMNA P02545 1/20 0.35
TNKS O95271 1/20 0.35
TNKS2 Q9H2K2 1/20 0.35
ATM Q13315 1/20 0.34
PDE9A O76083 1/20 0.34
MMP13 P45452 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17653349 0.87 AAK1 (0.45) AAK1ALDH1A1L3MBTL1MEN1HTT
SCHEMBL17653175 0.87 KDM4E (0.43) AAK1ALDH1A1L3MBTL1MEN1HTT
SCHEMBL17653150 0.83 AAK1 (0.49) AAK1ALDH1A1L3MBTL1MEN1HTT
SCHEMBL17653084 0.82 KDM4E (0.44) AAK1ALDH1A1L3MBTL1MEN1HTT
SCHEMBL17653266 0.79 AAK1 (0.46) AAK1KDM4EMMP13
SCHEMBL17653107 0.79 KDM4E (0.41) AAK1ALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL17653110 0.76 IMPDH2 (0.46) AAK1KDM4E
SCHEMBL17663471 0.73 AAK1 (0.68) AAK1
SCHEMBL17653214 0.71 GAA (0.38) AAK1ALDH1A1L3MBTL1HTTSMN1; SMN2
SCHEMBL17653327 0.70 GAA (0.43) ALDH1A1L3MBTL1HTTSMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3200797-A1 QUINAZOLINE-BASED KINASE INHIBITORS Bristol-Myers Squibb Company (US) 2017-08-09 EP disclosed
WO-2016053794-A1 QUINAZOLINE-BASED KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2016-04-07 WO disclosed